Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a... see more

TSX:SVA - Post Discussion

Sernova Corp > Doug Loe has done it again
View:
Post by steadfast on Jan 07, 2022 12:27pm

Doug Loe has done it again

Jan 18 2021   SVA trades at $2.87 in early trading.  Doug Loe issues a Target of $2.50
                     Momentum is destroyed.  HIs firm participates in Bot Deal @ $1.20
Jan  7, 2022   SVA opens at $2.21.  Doug Loe issues a Target of $2.50
                     Once again momentum is destroyed.
It is almost impossible to believe he can do this 2 years in a row. If he can't raise his
target after a year, he should not write at all.
If I was  Mgt   I would fire him today and ensure he never writes another report on SVA

This is beyond Ridiculous.  Dr T continually advises shareholders we are worth $1B U.S.
today due to Vertex/Semma deal.  That is $3.48 Can not $2.50.  Once the stock reaches $3.10, the bot deal wts get called and it is worth $40M to SVA.  A deal with a Pharma likely
adds another $1B US.
Doug has presented a new Challenge to the IR Guys, they are going to have to work harder
to get the momentum going and get the stock back to $2.21 this afternoon.  We had good
momentum going into Monday.  We cannot allow Doug to destroy the momentum in 2022.
Comment by Redbaron2211 on Jan 07, 2022 12:43pm
I think it's best to just ignore Doug Loe he is clearly disconnected from reality, Sernova and its investors are ready to leave him in the dust. 
Comment by MoneyMouth on Jan 07, 2022 12:50pm
Yeah Doug Loe is a complete imbecile. Sernova should have never gotten into bed with those snakes.
Comment by Redbaron2211 on Jan 07, 2022 12:58pm
It looks like he is just trying to get some recognition on his old PT and will likely reinstate another PT once new data is available.   He did the same last year, posting a PT a few days after the Jan data.  Hopefully this year without a financing looming he has the foresight to make a PT well above a potential break out.  
Comment by MustangSalley on Jan 07, 2022 1:22pm
I think Doug Loe and co don't want share price above $3.05 forced conversion price .They will do everything possible tokeep it below and delay exercising of the free warrants as long as possible . Just my intuition . Why all of sudden does that rat come and give guidance at the very last minute , the day before results are to be released. Coincidence .... I don't think so... MS
Comment by Redbaron2211 on Jan 07, 2022 1:51pm
Possible MS.  I feel like he's just trying to soak up exposure.  He won't change his PT without new data, but with all the attention Sernova is getting, it's a great time to take credit for previous calls.  I don't think Sernova will choose to force conversion any time soon, as they have enough cash and the warrant $ will trickle in with a price above 3$.  ...more  
Comment by donkeyfeathers on Jan 07, 2022 12:51pm
SF, Perfect summary!  The fix is in.  This "call" has everything to do with a "target" that is nothing more than self-serving drivel.  There is genuine fear that both houses in the bought deal will actually have to pony up because there is a very real - retail market lead - push to align share valuation with the public's expectations (diabetes cured??).   ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities